NRAS and chronic myelomonocytic leukemia: Our results are consistent with previous findings that NRasG12D targets the monocytic lineage cells to induce myelomonocytic proliferation, and that NRAS mutations are frequently identified in patients with chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML)30–33.